Taken together, these data suggest that INS mutations are more common in infants presenting with NDM at a younger age, however further large cohort studies are needed to establish the prevalence of INS mutations in patients presenting at a range of ages, especially in those who do not have autoantibodies to islet cell proteins. Here, INS is linked to neonatal diabetes mellitus.